Here’s a slightly edited and improved iteration of my article which was published in yesterday’s The American Spectator regarding the rapidly proliferating clinical and laboratory data that support the use of the inexpensive, safe and widely available antimalarial drug hydroxychloroquine to treat and prevent COVID-19 infections. I hope you find it to be interesting and useful. The $20 Solution to Coronavirus: ‘Anecdotal Evidence’ Is a Life-Saver | The American Spectator Over the weekend, the Food and Drug Administration (FDA) issued an emergency authorization for the use of hydroxychloroquine (HCQ) and chloroquine (CQ) to treat hospitalized COVID-19 patients. Simultaneously, the Department of […]